Stokes Healthcare Inc. dba Epicur Pharma – FDA 483, Oct 25, 2023
During an inspection from September 26 to October 25, 2023, the FDA observed significant deficiencies at Stokes Healthcare Inc. dba Epicur Pharma, an outsourcing facility in Mount Laurel, NJ. The inspection revealed widespread issues including unvalidated manufacturing processes for sterile drug products, inadequate aseptic processing controls, failures in quality control investigations, and non-compliant drug product labeling. These findings indicate a serious lack of adherence to cGMP requirements, particularly concerning the production and release of sterile human and animal drug products.
ID · 9872ca1f-dfc5-49af-9c44-be3a98afa7d6
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.